As of 2026-04-04, the Relative Valuation of TherapeuticsMD Inc (TXMD) is 0.45 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.00 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -77.6%.
The range of the Relative Valuation is 0.29 - 0.54 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 15.1x | 14.4x |
| Forward P/E multiples | 17.7x - 20.7x | 19.9x |
| Fair Price | 0.29 - 0.54 | 0.45 |
| Upside | -85.3% - -73.0% | -77.6% |
| Date | P/E |
| 2026-04-02 | 76.62 |
| 2026-04-01 | 76.62 |
| 2026-03-31 | 77.39 |
| 2026-03-30 | 76.24 |
| 2026-03-27 | 80.45 |
| 2026-03-26 | 85.05 |
| 2026-03-25 | 87.73 |
| 2026-03-24 | 87.73 |
| 2026-03-23 | 88.50 |
| 2026-03-20 | 85.82 |
| 2026-03-19 | 85.43 |
| 2026-03-18 | 85.05 |
| 2026-03-17 | 85.43 |
| 2026-03-16 | 83.14 |
| 2026-03-13 | 83.14 |
| 2026-03-12 | 87.35 |
| 2026-03-11 | 87.73 |
| 2026-03-10 | 88.12 |
| 2026-03-09 | 88.12 |
| 2026-03-06 | 86.20 |
| 2026-03-05 | 85.43 |
| 2026-03-04 | 82.75 |
| 2026-03-03 | 85.05 |
| 2026-03-02 | 85.82 |
| 2026-02-27 | 86.58 |
| 2026-02-26 | 86.58 |
| 2026-02-25 | 86.20 |
| 2026-02-24 | 86.20 |
| 2026-02-23 | 87.35 |
| 2026-02-20 | 88.12 |
| 2026-02-19 | 89.27 |
| 2026-02-18 | 88.88 |
| 2026-02-17 | 88.12 |
| 2026-02-13 | 90.41 |
| 2026-02-12 | 92.71 |
| 2026-02-11 | 93.10 |
| 2026-02-10 | 91.18 |
| 2026-02-09 | 95.01 |
| 2026-02-06 | 87.73 |
| 2026-02-05 | 83.90 |
| 2026-02-04 | 86.20 |
| 2026-02-03 | 89.27 |
| 2026-02-02 | 86.58 |
| 2026-01-30 | 82.75 |
| 2026-01-29 | 88.12 |
| 2026-01-28 | 81.99 |
| 2026-01-27 | 92.71 |
| 2026-01-26 | 106.12 |
| 2026-01-23 | 99.99 |
| 2026-01-22 | 97.69 |